Human papillomavirus type 16 (HPV16) is responsible for most cancers attributable to HPV infection and naturally occurring variants of the HPV16 E6 oncoprotein predispose individuals to varying risk for developing cancer. Population studies by us and others have demonstrated that the common Asian-American E6 (AAE6) variant is a higher risk factor for cervical cancer than the E6 of another common variant, the European prototype (EPE6). However, a complete understanding of the molecular processes fundamental to these epidemiological findings is still lacking. Our previously published functional studies of these two E6 variants showed that AAE6 had a higher immortalization and transformation potential than EPE6. Proteomic analysis revealed markedly different protein patterns between these variants, especially with respect to key cellular metabolic enzymes. Here, we tested the Warburg effect and hypoxia signalling (hallmarks of cancer development) as plausible mechanisms underlying these observations. Lactate and glucose production were enhanced in AAE6-transduced keratinocytes, likely due to raised levels of metabolic enzymes, but independent of hypoxia-inducible factor 1 alpha (HIF-1a) activity. The HIF-1a protein level and activity were elevated by AAE6 in hypoxic conditions, leading to a hypoxia-tolerant phenotype with enhanced migratory potential. The deregulation of HIF-1a was caused by the AAE6 variant's ability to augment mitogen-activated protein kinase/extracellular related kinase signalling. The present study reveals prominent underlying mechanisms of the AAE6's enhanced oncogenic potential.
INTRODUCTION
Human papillomaviruses (HPVs) are double-stranded DNA viruses that infect skin and mucosa. Over 200 genetic types of HPV have been identified to date, with HPV16 being responsible for most cervical cancer cases [1] . The oncogenicity of HPV16 largely results from the actions of the viral oncoproteins, E6 and E7. E6 is best known for its ability to induce degradation of the tumour suppressor protein, p53 and to induce hTERT activity, while E7 contributes to carcinogenesis by releasing the E2F1 cell cycle transcription factor from its complex with the retinoblastoma tumour suppressor protein [2] . In addition to these well-known functions, both E6 and E7 further contribute to malignant progression in a variety of aspects, a comprehensive review of which can be found in [2] and references therein.
HPV16 genetic variants are named after the geographical location in which they were first found: European prototype (EP) and Asian-American (AA). The E6 protein sequence of these two variants differs by three amino acid substitutions (Q14H/H78Y/L83V; EP>AA). Collectively, these naturally occurring changes in the E6 sequence have afforded the AAE6 a selective advantage in its carcinogenic potential over that of EPE6. While both variants are capable of immortalizing human primary foreskin keratinocytes (PHFKs) without the synergistic effects of E7, the E6 protein of the Asian-American variant (AAE6) is more potent than the European prototype E6 (EPE6) in doing so [3] . We showed that EPE6 requires E7 to induce malignant transformation, but that AAE6 alone (i.e. without E7) can transform keratinocytes in vitro with a greater ability to induce migration [3] . These results are in line with the epidemiological evidence indicating that infection with the AA HPV16 variant is a higher risk factor for high-grade intraepithelial neoplasia and progression to invasive cervical cancer than infection with EP HPV16 [4] [5] [6] [7] . Our previous data demonstrated that, in the presence of E7, AAE6 metabolizes glucose differently than EPE6, as certain regulatory enzymes of glycolysis [pyruvate kinase M2 (PKM2) and glyceraldehyde-3 phosphate dehydrogenase (GAPDH)] exhibited increased expression in AAE6 cells [8] . Demonstration of an altered metabolic phenotype is well documented in cancer cells, beginning with the discovery by Otto Warburg that glucose uptake and lactate production are enhanced in tumours [9] . Here, we show a Warburg effect independent of HIF-1a, but likely dependent on the increased expression of the metabolic enzymes PKM2 and GAPDH in AAE6-transduced keratinocytes [8, 9] . The augmented HIF-1a levels and activity in these cells, on the other hand, are due, at least in part, to AAE6's ability to activate mitogen-activated protein kinase (MAPK)/extracellular related kinase (ERK1/ 2) signalling.
RESULTS AND DISCUSSION
AAE6-transduced keratinocytes exhibit an altered morphology and display an enhanced Warburg effect in comparison to EPE6 The Warburg effect describes the phenomenon by which cancer cells take up increased amounts of glucose and metabolize it to lactate, which is considered necessary for malignancy, and interestingly, this property is shared by normal proliferating tissues [9] . It appears that increased glucose uptake is beneficial for the synthesis of macromolecules, such as phospholipids and nucleotides, that are required for cell proliferation [9] . Furthermore, lactate production is a contributing factor to cancer cell invasion, and is a key predictor of malignant progression in cervical cancer [10] [11] [12] [13] . Given that AAE6 alters the levels of key enzymes involved in sugar metabolism suggestive of a Warburg effect (i.e. increased glucose consumption and lactate production) [8] we tested whether glucose metabolism is altered between EPE6 and AAE6 cells and analysed both their relative glucose uptake and lactate production. In line with this notion, we found glucose uptake to be significantly higher (~1.65-fold increase, P<0.05) in cells harbouring the AAE6 variant, as determined by uptake of the fluorescently labelled glucose molecule, 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG; Fig. 1a ). Coupled with an increase in glucose consumption, cells transduced with AAE6 excrete significantly increased amounts of lactate into culture media ( Fig. 1a; ~1.40-fold increase, P<0.01). These findings may be related to the cellular morphology (Fig. 1b) . Compared to untransduced PHFKs, EPE6-transduced cells are smaller, but their growth pattern is similar, in that they grow spread out in dispersed colonies. In contrast, AAE6-transduced cells are much smaller and grow in tight clusters of rapidly proliferating cells. A subset of enlarged, senescent cells with abundant and sometimes rounded cytoplasm was only noted in EPE6 cultures, likely contributing to this variant's lower proliferation capacity. These transduced PHFKs have comparable levels of E6 expression, suggesting that differences in metabolic activity are independent of the E6 expression level ( [8] , Fig. 2a ).
AAE6-transduced keratinocytes show enhanced HIF-1a levels and activity compared to EPE6 under hypoxia A metabolic phenotype indicative of the Warburg effect can be initiated by several molecular mechanisms, including genetic or post-translational alterations in p53, MYC, AMPK, PI3K or HIF-1 [14] . We previously showed that in the presence of E7, AAE6 elevates the expression of several metabolic enzymes involved in glycolysis [8] , as well as carbonic anhydrase IX (CAIX [3] ), all of which are under the regulation of HIF-1a and promote tumourigenesis [15, 16] . Furthermore, we identified HIF-1a as a central factor in cancer progression resulting from infection by oncogenic viruses [17] . Thus, we sought to determine whether the enhanced Warburg effect of AAE6 was due to HIF-1a signalling. We first determined the relative levels of HIF-1a under normoxia, as regulation of the protein's a subunit level is a major mechanism by which HIF-1a activity is regulated [16] . We then sought to determine whether HIF-1a levels were differentially affected by these two HPV16 E6 variants under hypoxia, mimicking conditions in a tumour microenvironment. We found the relative levels of HIF-1a to be enhanced in a statistically significant manner (~1.5-fold) in cells with AAE6 in comparison to those with EPE6 under hypoxic (1 % O 2 ) culture conditions (Fig. 2a, P<0 .05). Densitometry analysis revealed no significant difference in E6 levels between both variant cell lines or between oxygen environments (P>0.05). Enhanced levels of HIF-1a under hypoxia were also found in the nucleus, with a~2.2-fold increase in AAE6-transduced keratinocytes in comparison to those transduced with EPE6 (Fig. 2b, P<0 .01). While levels of HIF-1a are also slightly elevated under normoxia, this difference was not statistically significant.
The expression of HIF-1a is increased in high-grade cervical intraepithelial lesions and early invasive carcinomas [18] . In agreement with significantly increased HIF-1a protein levels under hypoxic cell culture conditions, there is a significant 1.3-fold increase (P<0.05) in HIF-1a transcriptional activity under hypoxia in AAE6-transduced keratinocytes compared to EPE6-transduced cells (Fig. 2c) . Similarly, the expression of a HIF-1 target gene, glucose transporter 1 (GLUT-1), has been shown to correlate with increasing grades of cervical cancer lesions [19] [20] [21] . RTqPCR analyses revealed that, in accordance with the hypoxia-response element (HRE) luciferase assay results, the relative levels of GLUT-1 are significantly increased, by 1.5-fold (P<0.01), in AAE6-transduced keratinocytes under hypoxia only (Fig. 2d) . When comparing HIF-1a Western blot densitometry with luciferase and target gene values, the quantification and fold-change differences we report are comparable to those seen previously in the literature [22] .
Given the lack of a significant difference in HIF-1a activity or GLUT-1 transcription under normoxia, the increase in lactate production described herein seems to be independent of AAE6's ability to promote HIF-1a signalling. Rather, it is likely due to increased expression of PKM2 and GAPDH in AAE6-transduced keratinocytes, as we reported earlier [8] . Indeed, PKM2 is known to play a central role in regulating the Warburg effect [23] , and GAPDH was implicated as the rate-limiting factor in determining the rate of glycolytic flux in cancer cell metabolism [24] . HIF-1a activation under hypoxia is a central oncogenic phenomenon, suggesting that its raised levels in AAE6-transduced keratinocytes contribute to a hypoxia-tolerant phenotype required for HPV-induced tumourigenesis [17, 18] .
HIF-1a knockdown decreases hypoxic cell migration in AAE6 keratinocytes
The improved ability to adapt to the hypoxic tumour microenvironment may contribute to AAE6's increased risk for invasion and shorter time to cancer development, as it enables tumour progression [16] . To understand the role that HIF-1a plays in the aggressive phenotype of AAE6-transduced keratinocytes, we tested whether inhibition of HIF-1a affected the ability of cells to migrate through a collagen-coated polycarbonate membrane using 10 % FBS as a chemoattractant. In this context, AAE6 cells migrate to a significantly greater extent than EPE6 cells [3] . The use of siRNA was sufficient to knock down HIF-1a protein levels to nearly undetectable levels in both cell types and under both normoxia and hypoxia (Fig. 3a) . While HIF-1a siRNA had no effect on the ability of cells to migrate under 20 % O 2 culture conditions, knockdown of HIF-1a significantly inhibited the migratory ability of AAE6-transduced keratinocytes under hypoxic conditions (P<0.001) (Fig. 3b) . While there is a small decrease in migration of EPE6 cells under hypoxia with HIF-1a silenced, it is not statistically significant. These results are congruent with the effect seen in other cancer cell types, where a quantitative increase in HIF-1a leads to a concomitant increase in migratory potential [25] . Thus, because HIF-1 activity is higher in AAE6 cells under hypoxia, HIF-1 silencing has a greater effect on migration under these conditions in these cells compared to EPE6 cells.
AAE6 enhances HIF-1a levels and proliferation by acting on the MAPK (ERK1/2) pathway We next sought to determine the mechanism by which HIF-1 levels were increased in AAE6 keratinocytes. The mitogen-activated protein kinase (MAPK) pathway has been well documented to activate HIF-1 signalling post- (a) Glucose consumption was measured using 2-NBDG. Cells were incubated with or without 2-NBDG and lysed with NP40. The fluorescence of the lysates was determined using a fluorescent microplate reader and normalized to protein using untreated lysates as a negative control of background fluorescence (n=3). *, P<0.05; **, P<0.01; ***, P<0.001; Welch's two-sample t-test. Lactate production was assessed by measuring the levels of lactate in cell culture media using the BioVision lactate assay kit and normalized to total protein (n=6). *, P<0.05; **, P<0.01; ***, P<0.001; Welch's two-sample t-test. ) and cytosolic ('C') HIF-1a fractions of EPE6 and AAE6 PHFKs; a-tubulin and lamin B1 were used as a loading control for the cystolic and nuclear fractions, respectively (n=3). *, P<0.05; **, P<0.01; ***, P<0.001. (c) HIF-1 luciferase activity was assayed at 72 h following the transfection of HIF-1 Cignal reporter plasmids using the Dual-Glo Stop and Glo system (n=3). *, P<0.05; **, P<0.01; ***, P<0.001; two-way ANOVA followed by Tukey's HSD translationally through its direct phosphorylation of HIF1a [16] . Notably, proteins of the oncogenic HPV16, Epstein-Barr and hepatitis B viruses can act upstream of HIF-1a to enhance its protein levels and activity by promoting ERK1/2 phosphorylation [26] [27] [28] . Interestingly, HPV16 E6 variants harbouring an L83V mutation have been implicated in the differential regulation of MAPK/ERK signalling, which is hypothesized to be due to their increased ability to degrade E6-targeted protein 1 (E6TP1; [29] ). Hence, we wanted to investigate whether this pathway is altered in cells harbouring each of the E6 variants under study, as the naturally occurring AAE6 contains an L83V substitution. Nuclear translocation of HIF-1a (as also shown above) is essential for its transcription factor activity and was found to be inhibited by treatment with the mitogen-activated extracellular related kinase (MEK1/2) inhibitor, PD98059, in cells expressing the hepatitis B Virus X protein [28] . We therefore hypothesized that both an elevated HIF-1a protein level and its nuclear translocation are brought about by AAE6's ability to increase ERK1/2 phosphorylation.
We assessed whether activation of the ERK1/2 pathway is responsible for the elevated HIF-1a protein level we observed. First, we tested whether there was an increase in ERK1/2 signalling under normoxic culture conditions in AAE6-transduced cells compared to EPE6 cells. We found that the level of phosphorylated ERK1/2 (pERK) relative to total ERK1/2 (tERK) was enhanced approximately 1.5-fold in AAE6-transduced keratinocytes compared to EPE6-transduced keratinocytes (Fig. 4a, P<0 .05). Once activated (phosphorylated), pERK is subject to a negative feedback loop by MAPK phosphatases [30] , suggesting that an increased ratio of pERK1/2 to total ERK1/2 (tERK) is a reliable proxy to test the ability of MAPK pathway activation downstream of MEK. Even subtle changes in ERK1/2 activity have been shown to have significant consequences for its ability to modulate cellular phenotype, and they are of biological significance [31] . Treatment with the MEK1/2 inhibitor, PD98059, caused a statistically significant reduction of the HIF-1a protein level in AAE6 cells only, under both 20 % (10-fold reduction) and 1 % (2-fold reduction) O 2 conditions (Fig. 4b, P<0.001) . Further, the levels of HIF-1a under hypoxia are equal between variants following treatment with PD98059, meaning that ERK1/2 is likely the sole contributory factor to increased HIF-1a in AAE6 cells over EPE6 in the hypoxic environment. Surprisingly, there was some recovery of pERK after prolonged PD90859 exposure, most likely due to treating the cells with PD98059 for 24 h to deplete the pool of HIF-1a mRNA prior to placing the cells under continued normoxia or hypoxia for another 24 h. Consequently, at the time of cell harvest for Western blot, the effect of PD98059 is diminished. Nevertheless, pERK is still reduced compared to untreated cells, which results in a diminished HIF-1a level (Fig. 4a, b) .
The MAPK (ERK1/2) pathway also plays a significant role in activating gene expression that enhances proliferation in cancer cells, independent of its role in augmenting HIF-1a activity [31, 32] . Given that we have previously reported that AAE6-immortalized PHFKs exhibit increased cellular proliferation [3, 33] with a diverse phenotype from that of EPE6 (Fig. 1b) , we hypothesized that this difference in proliferative potential may also lie in AAE6's ability to enhance MAPK (ERK1/2) activity. Indeed, we found that inhibiting this pathway with PD98059 leads to a nearly complete inhibition of AAE6's enhanced proliferative advantage over EPE6 (Fig. 4c) . When being treated with PD98059, both cell types proliferate at the same rate, indicating that the quantitative increase in proliferation in AAE6 over EPE6 PHFKs is solely due to its ability to augment ERK1/2 signalling. Taken together, we conclude that AAE6 enhances HIF-1a levels and cell proliferation by acting on MAPK/ERK1/2, an upstream effector of both HIF-1 and cell cycle regulators.
CONCLUSION
Over the past several years, our laboratory has focused extensively on the biology of intratypic HPV16 variants [3, 8, 17, 33, 34] . In these studies, the goal has been to elucidate the ways in which 'higher-risk' HPV16 variants deregulate cellular pathways, accounting for their differing risk for cervical cancer development. In fact, they alluded to the possibility of changes in sugar metabolism and HIF-1 signalling, coupled with growth factor signalling, as central components in the activity of high-risk HPV16 variants. In the present study, we have unravelled two key oncogenic pathways (Fig. 5) by which AAE6 adopts a superior oncogenic phenotype over EPE6: AAE6 deregulates the cellular metabolism in a way that is reminiscent of the Warburg effect and enhances HIF-1 activity under the hypoxic conditions of the tumour microenvironment. The enhanced HIF-1 levels result from AAE6's ability to activate MAPK/ERK1/2 signalling -which in turn increases cell proliferation via ERK1/2's role in promoting the cell cycle [32] . Together, these characteristics explain AAE6's unique growth phenotype -evidenced in our earlier functional studies -mechanistically [3, 8] .
METHODS

Cell culture
Cell cultures were maintained in a 37 C incubator with 5 % CO 2 . DAPI-based staining was used for routine mycoplasma testing. We used PHFKs that had previously been retrovirally and stably transduced independently with either the HPV16 EPE6 or AAE6 variant gene coding for E6 proteins possessing a C-terminal haemagglutinin (HA) tag [8] .
All molecular experiments were conducted on these immortalized E6-transduced PHFKs. They were cultured in serum-free keratinocyte growth medium (KGM; Cell Applications Inc., cat. #131-500) replenished every other day. For hypoxia incubation, a Coy Laboratories hypoxic chamber/ glove box was used with a constant oxygen percentage of 1 % employed by nitrogen gas infusion. All experiments carried out under hypoxia were performed after 24 h of cell incubation in the hypoxia chamber. For experiments involving mitogen-activated protein kinase (MAPK) inhibition, PD98059 was used at a concentration of 50 µM overnight, prior to the cells being placed under 1 % O 2 or continued at 20 % O 2 for 24 h for normoxic controls to deplete HIF-1 pools. For growth curve data generation, 75 000 cells were seeded into 6-well-plates in the presence of 50 µM PD98059 or DMSO vehicle control and cells were counted every 48 h using a Bio-Rad TC10 cell counter (Bio-Rad Laboratories, Inc., cat. #145-0010).
Metabolic profiling: glucose uptake and lactate production To quantify the rate of glucose uptake, cells were cultured in glucose-free Krebs-Ringer phosphate HEPES-buffered saline (KRPH; 140 mM NaCl, 5 mM KCl, 2.5 mM CaCl 2 , 1 mM MgSO 4 , 1 mM KH 2 PO 4 , 10 mM HEPES) with a fluorescently tagged glucose analogue, 2-Deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG; Cayman Chemical, cat. #11046). The 2-NBDG was prepared as a 100 mM stock solution and added at a dilution of 1 : 1000 in KRPH to 80 % confluent cells in a six-well plate for 30 min. Cells were washed in DPBS and lysed in 150 µL of NP40 lysis buffer (1 % v/v NP-40, 1 % v/v sodium deoxycholate, 40 mM KCl, 20 mM TRIS-HCl, pH 7.4). Cells were scraped from the plate and centrifuged at 21 000 g for 5 min at 4
C to pellet the cell debris. From the cell lysate, fluorescence was read on a BioTek FL X 800 fluorescence microplate reader. The fluorescence of cell lysates not treated with 2-NBDG was subtracted from treated lysates to normalize for the intrinsic background fluorescence of the cell lysates not attributable to 2-NBDG uptake. Following fluorescence readings, protein amounts were determined using the Detergent Compatible (DC) protein assay (Bio-Rad Laboratories, Inc., cat. #5000111).
To determine the amount of lactate produced by each cell type, the EnzyChrom L-Lactate assay kit (BioAssays Systems, cat. #ECLC-100) was used per the manufacturer's instructions. Fresh medium was added to cells and they were incubated for 24 h. This medium was then removed from the cells and its lactate concentration was determined per the assay instructions. Cells were washed once with DPBS and then cells were lysed using RIPA buffer (see the Western blot analysis sub-section for the formulation) to obtain the protein amounts for normalization.
Western blot analysis
For the collection of proteins in whole-cell lysates, 100 µl of cold RIPA buffer (50 mM TRIS-HCl pH 7.5, 150 mM NaCl, 0.1 % SDS, 1 % sodium deoxycholate, 1 % Triton X-100, 5 mM EDTA, 10 mM NaF) with the fresh addition of 1 mM PMSF, a 1 : 100 dilution of Protease Inhibitor Cocktail (Sigma, cat. #P8340), 12.5 µl of activated Na 3 VO 4 (Sigma, Cat. #6508) and Phosphatase Inhibitor Cocktails 2 and 3 (Sigma, cat. #P5726 and #P0044) was added directly to cell plates, which were scraped for lysate collection. For nuclear and cytoplasmic fractionation, cells were lysed using NE-PER (Thermo Fisher Scientific, cat. #78833) per the manufacturer's instructions. Protein quantification was performed using a Detergent Compatible (DC) protein assay (Bio-Rad Laboratories, Inc., cat. #5000111). Equal amounts of protein for each sample were separated on a 4-20 % Mini-PROTEAN Precast SDS-PAGE gel (Bio-Rad, cat. #4561094) and transferred to a PVDF membrane.
Primary antibodies were diluted in 5 % non-fat dried milk in 0.05 % TBST and incubated overnight with agitation at 4 C. The primary antibodies were HIF-1a (1 : 500 dilution; BD Biosciences, cat. #610958), HA-E6 (1 : 500 dilution; Abcam, cat. #HA.C5), b-Actin (1 : 1000; Santa Cruz Biotechnology, cat. #sc-1616), lamin B1 (1 : 1000; Abcam, cat. #16048), a-Tubulin (1 : 4000; Sigma, cat. #T9026), p44/p42 extracellular related kinase 1/2 (T202/Y204) (1 : 1000; BD Bioscience, Cat. #612359), and p44+p42 MAPK (ERK1,2, Clone 3F8, 1 : 1000; Pierce, cat. #MA5-15605). Following incubation with a species-specific secondary antibody for 1 h at room temperature, the membrane was developed with an enhanced chemiluminescence kit (Perkin Elmer Inc., cat. #NEL100001EA) per the manufacturer's instructions.
The membrane was imaged with the BioSpectrum 410 UVP CCD camera and VisionWorks LS software. Densitometry for independent trials was performed using the density analysis tool provided with VisionWorks software relative to a loading control (b-actin for whole cell lysates, lamin B1 for nuclear lysates, tubulin for cytoplasmic lysates and total-ERK for analysis of ERK pathway induction). Densitometry was performed using consistent box sizes throughout the membrane, along with an automated background subtraction on a perlane basis by the Density Analysis tool. The data was then handled according to the Statistical analysis section below.
Quantitative reverse transcriptase PCR (RT-qPCR) RNA was extracted using the Arcturus PicoPure RNA isolation kit (Applied Biosystems, Carlsbad, CA, USA, cat. #KIT0204). Isolated RNA was converted to complementary DNA (cDNA) using the High Capacity cDNA archive kit per the manufacturer's instructions (Applied Biosystems, cat. #4368814). Relative mRNA levels for a transcript of interest were measured via real-time polymerase chain reaction (RT-qPCR) using a 7500 real-time PCR system (Applied Biosystems). Reaction mixtures containing 150 ng of cDNA, 45 µl TaqMan Gene Expression Master Mix (Applied Biosystems, cat. #4304437) and 4.5 µl TaqMan gene expression assay (Applied Biosystems, GLUT-1 assay ID #Hs00892681_m1 and HPRT1 assay ID #Hs99999909_m1) were assayed in a transparent MicroAmp optical 96-well reaction plate (Applied Biosystems, cat. #4306737). The cycle threshold (C t ) was obtained for each transcript of interest and the Livak method [35] was employed to determine the mRNA expression relative to HPRT1, which remained unchanged between variant cell type and oxygen culture conditions.
